For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Glenmark Pharma Slips Over 5% After DCGI Issues Notices

By Staff
|

On Monday, shares of Glenmark Pharmaceuticals Ltd fell over by 5 percent to an intraday low of Rs 405 after the Drug Controller General of India (DCGI) issued notices to the company seeking clarification over its alleged "false claims" about the use of anti-viral FabiFlu on COVID-19 patients with comorbidities and also over the "pricing" of the drug, on receiving a complaint from a member of Parliament.

Glenmark Pharma Slips Over 5% After DCGI Issues Notices
 

According to a PTI report, DCGI's Dr V G Somani in a letter to the company stated that his office received a representation from an MP that the total cost of the treatment with FabiFlu (favipiravir) will be around Rs 12,500 and that the "cost proposed by Glenmark is definitely not in the interest of the poor, lower middle class and middle-class people of India."

"Further it has been mentioned in the representation that Glenmark has also claimed that this drug is effective in co-morbid conditions like hypertension, diabetics, whereas in reality, as per protocol summary, this trial was not designed to assess the FabiFlu in comorbid condition," the letter as quoted by PTI said.

No clinically sufficient data specific to these conditions are available, the DCGI said in its letter.

"In view of this, you are requested to provide your clarification on the above points for taking further necessary action in the matter," it added.

Glenmark had initially fixed the price of the Fabiflu at Rs 103 per tablet, which took the overall cost of the 14-day regimen that includes 122 tablets to Rs 12,500. The company last week dropped the prices to Rs 75 per tablet that brought the cost down to Rs 9,150.

Fabiflu is the generic version of Favipiravir. It was approved by DCGI for treating mild COVID-19 patients in June.

Read more about: glenmark pharma coronavirus
Story first published: Monday, July 20, 2020, 11:15 [IST]
Company Search
Get Instant News Updates
Enable
x
Notification Settings X
Time Settings
Done
Clear Notification X
Do you want to clear all the notifications from your inbox?
Settings X
We use cookies to ensure that we give you the best experience on our website. This includes cookies from third party social media websites and ad networks. Such third party cookies may track your use on Goodreturns sites for better rendering. Our partners use cookies to ensure we show you advertising that is relevant to you. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on Goodreturns website. However, you can change your cookie settings at any time. Learn more